Randomized placebo-controlled trial of hen's egg consumption for primary prevention in infants

Johanna Bellach1, Veronika Schwarz1, Birgit Ahrens1

  • 1Department of Paediatric Pneumology and Immunology, Charité-Universitätsmedizin, Berlin, Germany.

Insights

Early introduction of hen's egg did not prevent allergy in infants. Introducing egg before 12 months may increase allergic reactions in infants already sensitized to egg.

Area of Science:

  • Pediatric Allergy
  • Immunology
  • Clinical Nutrition

Background:

  • Hen's egg allergy is a prevalent food allergy in early childhood.
  • Early intervention strategies are crucial for managing childhood allergies.

Purpose of the Study:

  • To evaluate the efficacy of early hen's egg introduction (4-6 months) in preventing hen's egg allergy.
  • To assess the safety of early egg introduction in a general infant population.

Main Methods:

  • A randomized, placebo-controlled trial involving 4- to 6-month-old infants without hen's egg sensitization.
  • Infants received either egg white powder (verum) or rice powder (placebo) 3 times weekly until 12 months.
  • Primary outcome: hen's egg sensitization (serum IgE levels); Secondary outcome: confirmed hen's egg allergy via food challenge.

Main Results:

  • No significant difference in hen's egg sensitization or allergy between the verum and placebo groups at 12 months.
  • The verum group showed a higher, though not statistically significant, risk for sensitization and allergy.
  • A notable percentage of infants screened were already sensitized or allergic to hen's egg.

Conclusions:

  • Early introduction of hen's egg (4-6 months) does not prevent sensitization or allergy in infants.
  • Early introduction may increase the risk of allergic reactions in already sensitized infants.
  • Current findings suggest caution regarding early egg introduction in the general infant population.
Abstract